NEU 1.99% $15.30 neuren pharmaceuticals limited

Ann: Trofinetide significant clinical benefit in Rett syndrome, page-32

  1. 1,940 Posts.
    lightbulb Created with Sketch. 34
    I wonder if there are any other neurobiologically-based drugs for the treatment of Rett syndrome and other neurodevelopmental disorders in the pipeline.... hang on a second... "hey boys and girls - don't throw out 2291 just yet"!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.30
Change
-0.310(1.99%)
Mkt cap ! $1.991B
Open High Low Value Volume
$15.83 $15.87 $15.26 $3.844M 247.4K

Buyers (Bids)

No. Vol. Price($)
13 3926 $15.30
 

Sellers (Offers)

Price($) Vol. No.
$15.32 372 14
View Market Depth
Last trade - 13.44pm 16/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.